Legal & Corporate Affairs Docs

SOP for Drafting and Reviewing of Legislation

PAU 36 Rev 4_August 2020 Standard Operating Procedures for Supplier Evaluation Processes

LC 05 Rev 6_July 2020 Standard Operating Procedure for Gazetting of Fees

LC 03 Rev 2_July Standard Operating Procedure for Reviewing Contracts

LC 03 Rev 2_July Standard Operating Procedure for Reviewing Contracts

Circular 5 of 2022 – Publication of Cancelled Premises and Persons’ Licences.

Medicines and Allied Substances Control (Import and Export of Precursors and Certain Chemical Substances) Regulations, 2010 (No.2)

Medicines and Allied Substances Control (Import and Export of Medicines) (Amendment) Regulations. 2010 (No. 3)

Medicines and Allied Substances Control (Import and Export of Medicines) (Amendment) Regulations. 2013 ( No.3) SI 48 of 2013

Dangerous Drugs (Amendment) Regulations,2019, Statutory Instrument 232 of 2019

Medicines and Allied Substances Control (Complementary Medicines) (Amendment) Regulations 2018, (No. 1)

Dangerous Drugs (Production of Cannabis for Medicinal and Scientific Use) Regulations, 2018 (Amendment)

SI 62 of 2018 – Dangerous Drugs (Production of Cannabis for Medicinal and Scientific Use) Regulations, 2018

Medicines and Allied Substances Control (General) (Amendment) Regulations, 2016(No.29), SI 99 of 2016

Medicines and Allied Substances Control (Import and Export of Precursors and Certain Chemical Substances) Regulations, 2008